FdaApplication

BLA 103948

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGenzyme Corporation
application_typeBLA
approval_date2001-05-07

Products (3)

ProductActive ingredientStrengthDosage form
CAMPATHALEMTUZUMAB30MG (10MG/ML)VIAL;INTRAVENOUS
LEMTRADAALEMTUZUMAB12MG/1.2ML (10MG/ML)VIAL;INTRAVENOUS
CAMPATHALEMTUZUMAB30MG/1MLInjection

3 products